Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp-A Usability Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 21 04 2020
revised: 11 05 2020
accepted: 12 05 2020
entrez: 21 5 2020
pubmed: 21 5 2020
medline: 6 10 2020
Statut: epublish

Résumé

To create a mobile application able to help patients follow medical treatments properly. We designed and developed a custom Android/iOS App to remind patients of the pharmaceutical drugs to be taken, of the visits and exams to attend, and to detect their compliance with their personal therapeutic plan. In this paper we describe the App development, UX/UI design, Gamification. TuTOR is an Android and iOS application designed to remind patients of the drugs to be taken, giving them all the information related to their therapeutic plans in a simple and non-invasive way. Thanks to a dedicated back-office, specially designed to meet specific medical information needs, the App can also help physicians detect their patients' compliance with their treatments and modify prescriptions in real time. The App also ensures a state-of-the-art approach to data security and privacy protection. The main feature of TuTOR is the smart therapy assistant, which features dedicated alarms to remind users of taking their prescription drugs. Thanks to the automatic synchronization with a local database, the alert system works even without connection to the Internet. Particular attention was paid during the App's design process: we looked to create an intuitive interface to ensure absolute ease of use, with state-of-the-art visual design aimed at maximizing user experience. Other relevant features include the App's ability to givevisual evidence of the most important drugs to be taken and its note-taking feature, which gives patients the possibility to note down indications on why a specific drug was skipped. The App also keeps track of upcoming medical exams, laboratory tests, and visits on a devoted calendar. It also helps patients by listing therapy contacts, such as physicians' phone numbers, and indicates all medical references by showing, for example, locations of relevant clinics and pharmacies on a map. Thanks to specific visual progress indicators and an innovative gamification approach, the App encourages users to faithfully follow therapy guidelines. With TuTOR, assessing the therapy's state of completion is quick and easy.Thanksto the privacy-by-design approach used, all data managed by the system is compliant with the European Privacy Regulation and it is not available to third parties. A mobile App for medication adherence might increase objectively and subjectively measured adherence.

Identifiants

pubmed: 32429245
pii: ijerph17103469
doi: 10.3390/ijerph17103469
pmc: PMC7277549
pii:
doi:

Substances chimiques

Piperidines 0
Protein Kinase Inhibitors 0
Pyrimidines 0
Pyrroles 0
tofacitinib 87LA6FU830

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pharmacotherapy. 2010 Apr;30(4):339-53
pubmed: 20334454
N Engl J Med. 2012 Aug 9;367(6):495-507
pubmed: 22873530
Int J Clin Pract. 2008 Jan;62(1):76-87
pubmed: 17983433
J Gen Intern Med. 1994 Feb;9(2):96-105
pubmed: 8164085
Arthritis Rheum. 2001 Dec;44(12):2737-45
pubmed: 11762933
JMIR Mhealth Uhealth. 2014 Mar 14;2(1):e11
pubmed: 25099993
Lancet. 2013 Feb 9;381(9865):451-60
pubmed: 23294500
BMJ. 2008 May 17;336(7653):1114-7
pubmed: 18480115
Eur J Prev Cardiol. 2016 Jun;23(9):975-85
pubmed: 26198723
Ann Rheum Dis. 2017 Jun;76(6):960-977
pubmed: 28264816
Arthritis Care Res (Hoboken). 2012 Jun;64(6):797-808
pubmed: 22556106
Medicine (Baltimore). 2016 Sep;95(36):e4446
pubmed: 27603339
Arthritis Rheum. 1992 May;35(5):498-502
pubmed: 1575785
Int J Med Inform. 2009 Dec;78(12):788-801
pubmed: 19717335
Pharm World Sci. 2009 Aug;31(4):426-431
pubmed: 19381860
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595

Auteurs

Savino Sciascia (S)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Massimo Radin (M)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Irene Cecchi (I)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Pierluigi Di Nunzio (P)

DNDG Srl, 10151 Turin, Italy.

Nicola Buccarano (N)

DNDG Srl, 10151 Turin, Italy.

Federico Di Gregorio (F)

DNDG Srl, 10151 Turin, Italy.

Milone Valeria (M)

Pharmacy Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy.

Sara Osella (S)

Pharmacy Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy.

Paola Crosasso (P)

Pharmacy Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy.

Marika Denise Favuzzi (MD)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Elena Rubini (E)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Silvia Grazietta Foddai (SG)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Simone Baldovino (S)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Dario Roccatello (D)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Daniela Rossi (D)

Center of Research of Immunopathology and Rare Diseases-Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, and SCDU Nephrology and Dialysis-ERKnet Member, S. Giovanni Bosco Hospital, Department of Clinical and Biological Sciences, 10154 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH